Patients are surprised and dismayed to learn that until very recently, there has been no equivalent technology to the mammogram (for breast cancer) for diagnosing cardiovascular disease. That is, there was no reliable way to image the diseased tissue in the coronary arteries that ruptured and caused heart attacks and strokes. Now that method exists, as of August 2022. Our office is referring to that test. Up to now, we have used a blood test using seven biomarkers that is very advanced is an accurate measure of risk, and generally correlates to the new imaging.